University Hospitals and Premier Inc.’s PINC AI™ Applied Sciences (PAS) Team Collaborate to Advance Clinical Research and Innovative Healthcare Solutions

CLEVELAND – University Hospitals (UH) in Northeast Ohio, one of the nation’s leading healthcare systems comprised of expert and renowned surgeons, doctors and clinicians, is collaborating with Premier Inc.’s PINC AI™ Applied Sciences (PAS) to advance clinical research, real-world evidence generation and explore the development of new solutions, interventions and other novel healthcare initiatives.

UH and PAS will work together in four distinct areas:

• Jointly leverage real-world data, clinical input and other research to evaluate novel, new therapies and interventions for commercial development.
• Conduct prospective research on specific care pathways and other interventions using real-world data and evidence (RWD/RWE).
• Improve the quality and speed of clinical trials, research and product development using artificial intelligence (AI) to help identify diverse trial participants more rapidly.
• Utilize natural language processing (NLP) to uncover the unstructured information contained within clinician notes, pathology reports and genomics results for early disease identification and intervention.

This research partnership will leverage standardized and connected data, including the PINC AI™ Healthcare Database which represents more than 1 billion individual inpatient and outpatient encounters from over 1,000 geographically diverse sites. These data assets will help initiate prospective research and clinical trial opportunities that are informed by comprehensive insights and encompass the full patient journey and SKU-level purchase data that helps researchers and providers understand product costs, inventory and utilization at the zip code, state and national levels.

“This partnership builds upon our efforts to help test methodologies, implement early detection/identification of patient populations in multiple disease states, and scale solutions in a standardized way,” said Denise Juliano, Life Sciences Group Vice President, PAS. “Together, University Hospitals and PAS will leverage RWD, research-ready trial sites and representative populations to generate real-world evidence to help develop therapies, create care pathways and introduce new care options. We feel this collaboration will generate better answers to key clinical concerns with greater transparency, equity and operational efficiency.”

Specifically, UH and PAS plan to focus on a variety of clinical areas including value-based projects related to equity and disparities, quality and value improvement in primary and specialty care, and research around chronic diseases such as oncology, Alzheimer’s disease and Parkinson’s disease.“We’re pleased to partner with PAS and tap into RWD to help generate RWE,” said Dr. Peter Pronovost, Chief Clinical Transformation Officer and Chief Quality Officer, UH. “Leveraging our combined data and research expertise will enable reduced research timelines, clinical care pathway development and testing, early disease intervention and help drive innovations in clinical, quality and operational effectiveness.”

###
Forward-Looking Statements
Matters discussed in this release that are not statements of historical or current facts, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Premier to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements in the conditional or future tenses or that include terms such as “believes,” “belief,” “expects,” “estimates,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. Forward-looking statements may include comments as to Premier’s beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties, many of which are outside Premier’s control. More information on potential factors that could affect Premier’s financial results is included from time to time in the “Forward-Looking Statements,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of Premier’s periodic and current filings with the SEC and available on Premier’s website at investors.premierinc.com. Forward-looking statements speak only as of the date they are made. Premier undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date.

Contact: UH Media Relations